Knowledge, Attitude and Practice of Clinician Regarding Reporting of Adverse Drug Reaction (ADR) in Dr. Panjabrao Deshmukh Memorial Medical College, Amravati

Author : Dudhe B.G, Bhore A.S

Introduction: Pharmacovigilance (PV) is essential to detect and prevent adverse drug reactions (ADR) after a drug is marketed. However, ADRs are significantly underreported worldwide. Objective: To assess knowledge, attitude and practice of clinician towards Pharmacovigilance, to get an in-sight into the causes of under-reporting of ADR and to suggest possible ways of improving current methods of ADR reporting. Material &Method: A cross sectional questionnaire-based study conducted on 117 medical practitioners in tertiary medical care hospital. Results: 57.75% of participants were aware of the concept of Pharmacovigilance. 80% of doctors have 5-25% patients with ADRs. Objectives of ADR monitoring are identify safe drugs (27%); calculate ADR incidence (27%); patients benefit (21%). Major encouraging factor for ADR reporting are patient safety (35%), improving drugs qualities (24%), Lack of time (26%) and lack of knowledge (23%) are major factors to discourage reporting of ADRs. Almost everyone is in favor of teaching pharmacovigilance to healthcare students during curriculum. Nearly 2/3rd of healthcare practitioners (60%) have reported ADR. Conclusion: There was huge gap between the ADR experienced and ADR reported by prescribing doctors. Participants agreed that reporting of ADR is necessary and pharmacovigilance should be taught in detail to healthcare professionals.

Full Text Attachment

Creative Commons License World Journal of Pharmaceutical Science is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at Permissions beyond the scope of this license may be available at